UIC scientists redesign asparaginase to minimize leukemia treatment side effects
Revolutionizing Pediatric Leukemia: A Safer, Effective Treatment on the Horizon Recent advances at the University of Illinois Chicago have the medical community buzzing with excitement as scientists rewrite the treatment playbook for pediatric leukemia. By redesigning a key treatment known as asparaginase, researchers aim to eradicate severe side effects and widen treatment applicability. This breakthrough … Read more